Lai Yee Cheong

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Prostate Cancer

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lai Yee Cheong, Baile Wang, Qin Wang, Leigang Jin, Kelvin H M Kwok, Xiaoping Wu, Lingling Shu, Huige Lin, Sookja Kim Chung, Kenneth King Yip Cheng, Ruby L C Hoo, Aimin Xu
Fibroblastic reticular cells in lymph node potentiate white adipose tissue beiging through neuro-immune crosstalk in male mice. Nature communications 14 (1) (2023)
Lai Yee Cheong, Baile Wang, Qin Wang, Leigang Jin, Kelvin H M Kwok, Xiaoping Wu, Lingling Shu, Huige Lin, Sookja Kim Chung, Kenneth King Yip Cheng, Ruby L C Hoo, Aimin Xu
Fibroblastic reticular cells in lymph node potentiate white adipose tissue beiging through neuro-immune crosstalk in male mice. Nature communications 14 (1) (2023)
Lai Yee Cheong, Baile Wang, Qin Wang, Leigang Jin, Kelvin H M Kwok, Xiaoping Wu, Lingling Shu, Huige Lin, Sookja Kim Chung, Kenneth King Yip Cheng, Ruby L C Hoo, Aimin Xu
Fibroblastic reticular cells in lymph node potentiate white adipose tissue beiging through neuro-immune crosstalk in male mice. Nature communications 14 (1) (2023)
Lai Yee Cheong, Baile Wang, Qin Wang, Leigang Jin, Kelvin H M Kwok, Xiaoping Wu, Lingling Shu, Huige Lin, Sookja Kim Chung, Kenneth King Yip Cheng, Ruby L C Hoo, Aimin Xu
Fibroblastic reticular cells in lymph node potentiate white adipose tissue beiging through neuro-immune crosstalk in male mice. Nature communications 14 (1) (2023)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)